Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Moderna, inc. crawled time : 14:30 save search
Merck and Moderna Initiate INTerpath-002, a Phase 3 Study Evaluating V940 (mRNA-4157) in Combination with KEYTRUDA® (pembrolizumab) for Adjuvant Treatment of Patients with Certain Types of Resected Non-Small Cell Lung Cancer
Published: 2023-12-11 (Crawled : 14:30) - biospace.com/
MRK | $126.88 -0.05% -0.13% 7.5M
|
Health Technology
|
| O: 1.06%
H: 0.59%
C: -0.46%
MRNA | News S | $107.87 3.26% 3.16% 2.4M
|
Health Technology
|
| O: -0.47%
H: 3.28%
C: 2.58%
rna-4157 keytruda lung merck cancer cell treatment study
UMass Chan Medical School announces research collaboration with Moderna to examine impact of Cytomegalovirus (CMV) in young children
Published: 2022-03-22 (Crawled : 14:30) - biospace.com/
MRNA | News S | $107.87 3.26% 3.16% 2.4M
|
Health Technology
|
| O: 0.0%
H: 7.2%
C: 6.47%
research collaboration children
COVID-19 Update: Omicron BA.2 Surges, Long COVID and Mental Health
Published: 2022-03-15 (Crawled : 14:30) - biospace.com/
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: 1.37%
H: 0.0%
C: 0.0%
MRNA | News S | $107.87 3.26% 3.16% 2.4M
|
Health Technology
|
| O: 4.13%
H: 1.11%
C: -5.22%
covid-19 health covid
Moderna Announces Additional 20 Million Doses of COVID-19 Vaccine to COVAX for Supply in 2021 and New Additional Supply Agreement for 2022
Published: 2021-12-10 (Crawled : 14:30) - biospace.com/
MRNA | News S | $107.87 3.26% 3.16% 2.4M
|
Health Technology
|
| O: -17.85%
H: 0.0%
C: 0.0%
covid-19 covid vaccine
Cellarity Appoints Biopharmaceutical Executive Ian Estepan to its Board of Directors
Published: 2021-12-08 (Crawled : 14:30) - biospace.com/
OMGA | $2.345 -1.88% -1.92% 300K
|
|
| O: -0.6%
H: 18.84%
C: 17.76%
SANA | $8.09 2.02% 1.98% 1.7M
|
|
| O: 0.62%
H: 5.01%
C: 3.49%
SGTX | $22.47 -2.56% 0.0% 0
|
Health Technology
|
| O: -0.31%
H: 8.49%
C: 2.52%
MCRB | $0.7629 22.14% 18.13% 12M
|
Health Technology
|
| O: 0.0%
H: 1.25%
C: -4.08%
SRPT | $117.065 0.09% 0.09% 440K
|
Health Technology
|
| O: 0.79%
H: 2.56%
C: 0.02%
RUBY | $0.057 -99.3% 760K
|
Health Technology
|
| O: 0.76%
H: 2.12%
C: 1.67%
MRNA | News S | $107.87 3.26% 3.16% 2.4M
|
Health Technology
|
| O: 5.2%
H: 2.09%
C: 0.36%
FHTX | $5.135 1.68% 1.66% 46K
|
Health Technology
|
| O: -0.83%
H: 11.71%
C: 7.25%
EVLO | $0.3165 -87.39% 710K
|
Health Technology
|
| O: 0.23%
H: 3.78%
C: 1.15%
DNLI | $16.11 0.75% 0.74% 1.1M
|
Health Technology
|
| O: -0.11%
H: 4.87%
C: 4.15%
CDAK | $0.057 -55.99% -131.25% 0
|
Health Technology
|
| O: 2.97%
H: 0.0%
C: 0.0%
AXLA | $4.58 -56.33% 42K
|
Health Technology
|
| O: 0.81%
H: 8.41%
C: 6.45%
biopharma
Moderna to Present at Upcoming Investor Conferences in December 2021
Published: 2021-11-22 (Crawled : 14:30) - biospace.com/
MRNA | News S | $107.87 3.26% 3.16% 2.4M
|
Health Technology
|
| O: 1.63%
H: 7.81%
C: 5.45%
conference
Moderna Announces FDA Authorization of Booster Dose of COVID-19 Vaccine in the U.S. for Adults 18 Years and Older
Published: 2021-11-19 (Crawled : 14:30) - biospace.com/
MRNA | News S | $107.87 3.26% 3.16% 2.4M
|
Health Technology
|
| O: 5.57%
H: 3.55%
C: -0.62%
covid fda vaccine order
Moderna Tops BioSpace’s 2022 Best Places to Work Ranking in Large Employer Category
Published: 2021-11-17 (Crawled : 14:30) - biospace.com/
MRNA | News S | $107.87 3.26% 3.16% 2.4M
|
Health Technology
|
| O: 0.53%
H: 0.0%
C: 0.0%
space spac
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.